Joke Tio
Muenster, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Largazole targets Musashi protein expression via miR-125b-5p and sensitizes triple-negative breast cancer cells to radiation.
Journal: Frontiers in pharmacology
Published: November 12, 2025
Prediction of survival after de-escalated neoadjuvant therapy in HER2-positive early breast cancer: a pooled analysis of three WSG trials.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 30, 2025
Pharmacological inhibition of myostatin effectively ameliorates osteolytic lesions in syngeneic and xenograft breast cancer mouse models.
Journal: Oncogene
Published: January 22, 2025
Maternal mastitis and streptococcal toxic shock syndrome risk from breastfeeding children with scarlet fever: case report and literature review.
Journal: The Lancet. Infectious diseases
Published: June 20, 2024
The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy-A Retrospective Multi-Center Cohort Study.
Journal: Cancers
Published: March 21, 2024
Fat grafting in breast surgery: a retrospective single-breast centre 6-year experience.
Journal: Archives of gynecology and obstetrics
Published: March 05, 2024
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trial.
Journal: Frontiers in oncology
Published: December 12, 2023
Correction of the Tuberous Breast with Fat Grafting and Implant: Techniques, Evaluation with BREAST-Q, and Preliminary Results.
Journal: Aesthetic plastic surgery
Published: October 06, 2023
Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer.
Journal: JNCI cancer spectrum
Published: August 24, 2023
Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression.
Journal: Cell communication and signaling : CCS
Published: March 15, 2023
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 22, 2023
Last Updated: 09/26/2026